Macrophage migration inhibitory factor in inflammasome formation and macrophage recruitment by cervical squamous cell carcinoma cells

作者：Qianqian Zhang, Mengxin Wang, Suhui Wu · 发表于：Oncology Letters · 年份：2025 · DOI：10.3892/ol.2025.14910 · 被引用次数：9 · 研究领域：Macrophage Migration Inhibitory Factor

Despite the demonstrated efficacy of immune checkpoint blockade therapies in various types of cancer, their efficacy in cervical cancer is limited. A crucial pro‑inflammatory cytokine, macrophage migration inhibitory factor (MIF), is highly expressed in various types of cancers and contributes to tumor progression via the regulation of inflammatory responses and the tumor microenvironment. The present study aimed to explore the role of MIF in cervical squamous cell carcinoma (CSCC). Western blotting, reverse transcription‑quantitative polymerase chain reaction, Cell‑Counting Kit‑8, flow cytometry and enzyme‑linked immunosorbent assays were used to investigate the effects of MIF on CSCC progression and in the formation of inflammasomes using SiHa cells. Transcriptome and proteome sequencing were combined to screen for key effector proteins of MIF. Moreover, in vitro co‑culture experiments were used to evaluate the roles of MIF and TSC22 domain family protein 3 (TSC22D3) as inflammatory tumor‑promoting factors in macrophage recruitment and polarization induction. The results indicated that MIF was highly expressed in CSCC with lymph node metastasis, positively associated with cervical cancer stage, and associated with a poor prognosis. MIF was also found to promote the progression of CSCC cells and to be associated with inflammasome activation. Multi‑omics screening results indicated that TSC22D3 may be an important MIF interacting factor. Moreover, MIF and TSC22D3 facilitate...